Form 4: Brown-Forman Director Mark Clouse Receives Significant Deferred Stock Unit Grant
Insider Transaction Report
Brown-Forman Corporation Director Mark A. Clouse was granted 7,602.7176 Deferred Stock Units, increasing his beneficial ownership to 17,108.9029 units.
Summary
- Mark A. Clouse, a Director of Brown-Forman Corporation, acquired 7,602.7176 Deferred Stock Units (DSUs).
- The transaction occurred on July 24, 2025.
- Each DSU represents the right to receive one share of the Company's Class A common stock.
- The grant was based on the closing price of Class A common stock on July 24, 2025, which was $30.91 per share.
- Following this transaction, Clouse beneficially owns a total of 17,108.9029 DSUs.
- DSUs vest over the course of the Board year and are paid out in Class A common stock on the first February 1 that is at least six months after the director's termination from Board service.
- Participants are also credited with DSU equivalents on dividend payment dates.
Sentiment
Score: 7
Explanation: The grant of equity compensation to a director is generally a positive sign of alignment between management and shareholders, indicating confidence in the company's long-term performance. It is a routine transaction, so the sentiment is moderately positive rather than highly impactful.
Positives
- The grant of Deferred Stock Units aligns the interests of Director Mark A. Clouse with those of shareholders, as the value of his compensation is tied to the company's stock performance.
- Increased equity ownership by a director can signal confidence in the company's long-term prospects.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction. It solely reports an insider transaction.
Industry Context
This Form 4 filing reports an individual insider transaction and does not provide information relevant to broader industry trends or competitor analysis. Director compensation via equity is a common practice across various industries to align management interests with shareholders.
Comparison to Industry Standards
- The practice of compensating non-employee directors with deferred stock units is a common corporate governance practice across publicly traded companies, aligning director incentives with long-term shareholder value.
- The specific value of the grant (7,602.7176 DSUs at $30.91 per share, totaling approximately $235,000) would typically be benchmarked against director compensation packages at peer companies within the consumer staples or beverage industry, such as Constellation Brands (STZ), Diageo (DEO), or Pernod Ricard (RI.PA), to assess its competitiveness and appropriateness.
- The vesting schedule, which ties payout to termination from Board service, is a standard mechanism to encourage long-term commitment and stewardship.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Program Reference | The filing references the "Brown-Forman Corporation Amended and Restated Non-Employee Director Deferred Stock Unit Program," indicating an established corporate governance framework for director compensation. | NA | Confirms the company's structured approach to director compensation, aligning with best practices for attracting and retaining qualified board members. |
Related Party Transactions
- The DSU grant to a director is a standard, disclosed compensation arrangement under the company's established program, which is a common form of related party transaction in corporate governance.
Stakeholder Impact
- Shareholders: The DSU grant aligns the director's interests with shareholders, potentially fostering better long-term decision-making. It also represents a form of dilution upon conversion, though typically minor.
- Employees: No direct impact on employees is indicated.
- Customers/Suppliers/Creditors: No direct impact on these stakeholders is indicated.
Next Steps
- DSUs will vest over the course of the Board year.
- DSUs will be paid out in Class A common stock on the first February 1 that is at least six months following the director's termination from Board service.
Key Dates
| Date | Description |
|---|---|
| 07/24/2025 | Date of earliest transaction, when 7,602.7176 Deferred Stock Units were granted to Mark A. Clouse. |
| 07/25/2025 | Date the Form 4 filing was signed by Karleen M. Finnegan, Attorney in Fact for Mark A. Clouse. |
| February 1 | Date DSUs are paid out in Class A common stock, provided it is at least six months following the director's termination from Board service. |
Recommendation
holdThis Form 4 filing reports a routine equity grant to a director, which is a standard compensation practice and generally viewed as a positive for aligning interests. However, it does not contain new financial performance data, strategic shifts, or other material information that would warrant a change in investment recommendation based solely on this filing. It confirms ongoing corporate governance practices.
Keywords
Brown-Forman, BFA, BFB, Mark Clouse, Director Compensation, Deferred Stock Units, DSU, Insider Ownership, SEC Form 4, Equity Grant
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.